Brose, M. S., Nutting, C. M., Jarzab, B., Elisei, R., Siena, S., Bastholt, L., . . . Schlumberger, M. J. (2014). Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: A randomized, double-blind, phase 3 trial. Lancet.
Citação norma ChicagoBrose, Marcia S., et al. "Sorafenib in Locally Advanced or Metastatic, Radioactive Iodine-refractory, Differentiated Thyroid Cancer: A Randomized, Double-blind, Phase 3 Trial." Lancet 2014.
MLA引文Brose, Marcia S., et al. "Sorafenib in Locally Advanced or Metastatic, Radioactive Iodine-refractory, Differentiated Thyroid Cancer: A Randomized, Double-blind, Phase 3 Trial." Lancet 2014.
警告:這些引文格式不一定是100%准確.